Evidence map›Paper›PMID 25284702›Full record

Observational studyJournal of the American Geriatrics Society2014

Gastroprotective agent underuse in high-risk older daily nonsteroidal anti-inflammatory drug users over time.

Zachary A Marcum, Joseph T Hanlon, Elsa S Strotmeyer, Anne B Newman, Ronald I Shorr, Eleanor M Simonsick, Douglas C Bauer, Robert Boudreau, Julie M Donohue, Subashan Perera and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of the American Geriatrics Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zachary A MarcumDivision of Geriatric Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Joseph T Hanlon
Elsa S Strotmeyer
Anne B Newman
Ronald I Shorr
Eleanor M Simonsick
Douglas C Bauer
Robert Boudreau
Julie M Donohue
Subashan Perera
Health, Aging and Body Composition Study
University of Pittsburgh · USGeriatric Research Education and Clinical Center · USNational Institute on Aging · USUniversity of California, San Francisco · US

Funding

VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Caterina Rosano · 2004 to 2026
$28.6M
Pitt Integrated Clinical and Geroscience Research Training ProgramT32AG021885 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Aditi U Gurkar · 2003 to 2026
$6.7M
Peripheral Nerve Function Decline in an Aged CohortR01AG028050 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STROTMEYER, ELSA S. · 2007 to 2015
$3.5M
End of Life in the Very OldR01NR012459 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALBERT, STEVEN M, LUNNEY, JUNE R · 2011 to 2015
$2.7M
Biomarker Research in Musculoskeleton DiseaseK24AR051895 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BAUER, DOUGLAS C · 2005 to 2015
$1.5M
DYNAMICS OF HEALTH .AGING . AND BODY COMPOSITION /Pittsburgh/-260962101N01AG062101 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1996 to 2004
$996k
Longitudinal Impact of CNS Polypharmacy on Geriatric SyndromesR01AG027017 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HANLON, JOSEPH T · 2006 to 2012
$801k
DYNAMICS OF HEALTH . AGING . AND BODY COMPOSITION /Memphis/-26062103N01AG062103 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · 1996 to 2004
$793k
UPITT Program for Pharmaceutical Outcomes Research in AgingK07AG033174 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HANLON, JOSEPH T · 2009 to 2013
$461k
HEALTH ABC--COORDINATING UNIT /California/-260062106N01AG062106 · NIA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · 1996 to 2004
$109k
Intramural NIH HHSNIAMS NIH HHS K24 AR051895NIA NIH HHS K07 AG033174NIA NIH HHS K07AG033174NIA NIH HHS N01-AG-6-2101NIA NIH HHS N01-AG-6-2103NIA NIH HHS N01-AG-6-2106NIA NIH HHS P30 AG024827NIA NIH HHS P30AG024827NIA NIH HHS R01 AG027017NIA NIH HHS R01AG027017NIA NIH HHS R01 AG028050NIA NIH HHS R01AG028050NIA NIH HHS T32 AG021885NINR NIH HHS R01 NR012459
6 · The paper itself

Abstract

objectivesTo examine whether older adults taking nonsteroidal anti-inflammatory drugs (NSAIDs) decreased the underuse of gastroprotective agents over time.

designBefore-and-after study.

settingHealth, Aging and Body Composition Study.

participantsDaily users of a NSAID (prescription and over the counter (OTC)) at visits in 2002-03 (preperiod; n = 404) and 2006-07 (postperiod; n = 172). The sample had a mean ± standard deviation age of 78.2 ± 2.7 at the preperiod visit and 81.9 ± 2.7 at the postperiod visit. The majority were white and female and had 12 or more years of education. MEASUREMENTS: Underusers were defined as persons taking nonselective NSAIDs who were at risk of peptic ulcer disease (PUD; because of current warfarin or glucocorticoid use or history of PUD) and not using a proton pump inhibitor (PPI) or persons taking cyclooxygenase 2 (COX-2) selective NSAIDs and aspirin who were at risk of PUD (having at least one risk factor) and not using a PPI.

resultsDaily NSAID use decreased from 17.6% to 11.3% (P < .001), and gastroprotective agent underuse decreased from 23.5% to 15.1% (P = .008). Controlling for important covariates, having prescription insurance was somewhat protective against underuse in the preperiod (adjusted odds ratio (AOR) = 0.78, 95% confidence interval (CI) = 0.46-1.34; P = .37), but more so and significantly in the postperiod (AOR = 0.41, 95% CI = 0.18-0.93; P = .03). Having prescription insurance was more protective in the post- than in the preperiod (less gastroprotective agent underuse; adjusted ratio of OR = 0.53, 95% CI = 0.22-1.29; P = .16), but this increased protection was not statistically significant.

conclusionIn older daily NSAID users at high risk of PUD, having prescription insurance and adequate gastroprotective use was more common in the post- than in the preperiod.

Indexed as

AgedAged, 80 and overAnticoagulantsAnti-Inflammatory Agents, Non-SteroidalAspirinControlled Before-After StudiesCyclooxygenase 2 InhibitorsFemaleHumansInsurance, Pharmaceutical ServicesMalePeptic UlcerProspective StudiesProton Pump InhibitorsWarfarinAnticoagulantsAnti-Inflammatory Agents, Non-SteroidalAspirinCyclooxygenase 2 InhibitorsProton Pump InhibitorsWarfaringastroprotectionnonsteroidal anti-inflammatory drugolder adults

Identifiers

PMID25284702
PMCPMC4206578
OpenAlexW2033105349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.